What is Immunax?

Immunax’s active ingredient VDBP-MAF is a complex protein produced by the sequential deglycosylation of Vitamin D Binding Protein (VDBP). VDBP-MAF is a naturally-occurring messenger molecule that directs and coordinates immune cells. Developed by our research team to support and optimize immune function, Immunax activates the body’s natural immune defense systems and improves clinical outcomes for patients with weakened immune function.

Key Features:

  • Lyophilized product
  • No cold-chain shipping or storage
  • Stable shelf-life at room temperature for over 1 year
  • Classified as a nutritional supplement
  • Made in GMP certified lab
  • Third-party tested for sterility
  • Confirmed transcriptomic verification of activity
  • Exceeds LPS standard activation of macrophages

Immune Enhancement with Diverse Clinical Applications

Immunax functions like the commanding officer of your immune system. VDBP-MAF is a messenger protein that regulates the immune response. All healthy individuals naturally produce VDBP-MAF. Unfortunately, in people with chronic diseases it is often suppressed or depleted. iMAP therapy provides therapeutic benefits for a range of conditions, including:

  • Cancer
  • Neurological disorders
  • Autoimmune conditions
  • Chronic infections
  • Immune enhancement

VDBP-MAF: Immune Support and Enhancement

As a stabilized vitamin D protein complex containing both precursor (VDBP) and active (VDBP-MAF) ingredients, Immunax exerts its actions through the vitamin D axis and pathways to modulate macrophage activity. It boosts innate immune function by increasing vitamin D half-life and activates macrophages, which coordinate an integrated immune response.

Activated macrophages have diverse positive actions in the human body such as eliminating cancer cells, protecting against infections, and initiating repair and regeneration of the brain and central nervous system.

Over 30+ years of scientific research shows that Immunax may help to promote a wide range of beneficial physiological effects. Different effects will provide therapeutic benefits for different diseases.

  • Rebuilds the immune system (which cannot function without VDBP-MAF).
  • Stimulates macrophages (which kill cancer cells).
  • Recruits other immune cells for a coordinated immune response.
  • Combats cancer cell growth and metastatic potential (ability to spread).
  • Inhibits the blood supply to tumors (angiogenesis)
  • Induces cancer cell apoptosis (programmed cell death)
  • Transforms cancer cells into healthy cells (reverses cancer cell phenotype)
  • Prevents secondary tumor growth and secondary infections
  • Suppresses cancer gene expression (HER2 oncogene)
  • Counteracts cancer treatment-related side effects and toxicity
  • Modulates an overactive immune system
  • Alleviates chronic pain and peripheral neuropathy
  • Stimulates neurogenesis and neuroplasticity (brain repair and regeneration)
  • Increases mitochondrial energy production
  • Balances the endocannabinoid system and reduces inflammation
  • Fights chronic and recurrent infections
  • Induces nitric oxide synthesis and release
  • Activates osteoclasts and promotes bone resorption